GlucoTrack (GCTK) Revenue & Revenue Breakdown
GlucoTrack Revenue Highlights
00
Main Geography (Y)
Europe
GlucoTrack Revenue by Period
GlucoTrack Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | -100.00% |
| 2019-12-31 | $208.76K | 380.05% |
| 2018-12-31 | $43.49K | -92.62% |
| 2017-12-31 | $589.46K | -3.63% |
| 2016-12-31 | $611.69K | 327.26% |
| 2015-12-31 | $143.17K | 139.51% |
| 2014-12-31 | $59.77K | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | - |
GlucoTrack generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
GlucoTrack Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $42.00K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $-2.27K | 100.00% |
| 2020-09-30 | - | -100.00% |
| 2020-06-30 | $97.00 | -95.54% |
| 2020-03-31 | $2.17K | -96.83% |
| 2019-12-31 | $68.51K | 1540.89% |
| 2019-09-30 | $4.17K | -96.22% |
| 2019-06-30 | $110.52K | 332.35% |
| 2019-03-31 | $25.56K | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | -100.00% |
| 2018-06-30 | $15.28K | -45.84% |
| 2018-03-31 | $28.21K | -93.91% |
| 2017-12-31 | $463.58K | 2118.09% |
| 2017-09-30 | $20.90K | 139.02% |
| 2017-06-30 | $8.74K | -90.91% |
| 2017-03-31 | $96.24K | -25.69% |
| 2016-12-31 | $129.51K | 1046.23% |
| 2016-09-30 | $11.30K | -97.04% |
| 2016-06-30 | $381.73K | 328.20% |
| 2016-03-31 | $89.15K | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | -100.00% |
| 2015-06-30 | $67.34K | -11.19% |
| 2015-03-31 | $75.83K | 133.55% |
| 2014-12-31 | $32.47K | 18.88% |
| 2014-09-30 | $27.31K | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | - |
GlucoTrack generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
GlucoTrack Revenue Breakdown
GlucoTrack Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 19 | Dec 18 |
|---|---|---|
| Europe | $208.46K | $41.49K |
| Asia and Pacific | $300.00 | $2.00K |
Latest
GlucoTrack's latest annual revenue breakdown by geography, as of Dec 19: Europe (99.86%), and Asia and Pacific (0.14%).
GlucoTrack Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MHUA | Meihua Medical | $97.10M | $48.91M |
| PDEX | Pro-Dex | $53.84M | $14.89M |
| ZJYL | Jin Medical | $19.82M | $9.57M |
| AVGR | Avinger | $7.65M | $1.65M |
| NXGL | NEXGEL | $4.09M | $1.44M |
| POAI | Predictive Oncology | $1.78M | $345.69K |
| LUCY | Innovative Eyewear | $1.15M | $253.60M |
| GCTK | GlucoTrack | - | - |
| MBOT | Microbot Medical | - | - |
| STSS | Sharps | - | - |